Get started
Work

The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody

Year: 2011
Type: article
DOI: 10.1038/ncomms1615
Authors: Alexander D. Douglas, Andrew R. Williams, Joseph J. Illingworth, Gathoni Kamuyu, Sumi Biswas, Anna L. Goodman, David H. Wyllie, Cécile Crosnier, Kazutoyo Miura, Gavin J. Wright, Carole A. Long, Faith H. Osier, Kevin Marsh, Alison V. Turner, Adrian V.S. Hill, Simon J. Draper
Institutions: University of Oxford, Jenner Institute, Kenya Medical Research Institute, KEMRI-Wellcome Trust Research Programme, Wellcome Sanger Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases
Language: English
Field: Medicine
Open Access status: bronze
Funders: Foundation for the National Institutes of Health, Bill and Melinda Gates Foundation, Wellcome Trust, University of Oxford, National Institutes of Health, National Institute of Allergy and Infectious Diseases
Awards: G1404758650, Comprehensive analysis of the antibody targets of plasmodium falciparum merozites and identification of antigens important in the developmnet of naturally-aquired immunity to malaria., T Cell Inducing Vaccines., Human and Veterinary Vaccinology., Wellcome Trust PhD Programme for Clinicians at the University of Oxford: 'Investigation of the role of Plasmodium falciparum EBA and RH family antigens in immune evasion and as multi-antigen vaccine candidates.', G434908359, Human and Veterinary Vaccinology., Understanding the genetic basis of common human diseases: core funding for the Wellcome Trust Centre for Human Genetics., G7167154123, Comprehensive analysis of the antibody targets of plasmodium falciparum merozites and identification of antigens important in the developmnet of naturally-aquired immunity to malaria.
OpenAlex ID: W2090211342
FWCI: 18.23
Cites: 60
Cited by: 272
Related to: 10